Algo version: 0.98b
GRFS is listed at the NASDAQ Exchange
GRFS [GRFS]
NASDAQ Sector: Healthcare Industry:Drug Manufacturers—General

Is GRFS stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Grifols S.A. pays dividends. Last time was Monday 14th of June 2021 where the investors holding the stock on Thursday 3rd of June 2021 were paid $0.43850 per share. Over the last 16 times between 2013 and 2021, Grifols S.A. has paid $3.8145 with an average of $0.24 per share.

Sorry, we do not have any analyst data for this ticker

On Friday 17th of October 2014, Grifols S.A. had a stock price of $16.48. If you invested back then, your return now would be a loss of $-7.98 per share or -48.42%

Yes, the average daily trading liquidity for Grifols S.A. is $11.08 million. You should therefore be able to get in and out of your positions relatively fast.

Grifols S.A. has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a low cash flow to debt ratio of 0.04, the company's ability to pay off the debt is limited. The company has a very low net profit margin of 2.23%, which is challenging.

We have calculated the inflation risk for Grifols S.A. to be medium [0.65 out of 1]